Upcoming Meeting of MedInvest Oncology Investor Conference Series Scheduled for Tuesday, June 28 - Wednesday, June 29, 2022

Conference.jpg

The upcoming Meeting of the MedInvest Oncology Investor Conference Series will be hosted on June 28-29, 2022 in New York City.  The National Cancer Institute will be the Presenting Partner.   

The event will feature keynote talks, panels, and corporate presentations from over 40 companies in the cancer space.  Over 100 investors spanning venture capital, public funds, foundations, family offices and government grant making entities are expected to attend.

 

Conference speakers include:

Dr. Keith Fhaherty - Co-Founder Loxo Oncology | Director of Clinical Research at the Massachusetts General Hospital | Director of the Henri and Belinda Termeer Center for Targeted Therapy at Mass General

Dr. Niels Emmerich - Global Head of Search and Evaluation, Abbvie

Dr. Brian Leyland-Jones - CMO NFCR | Former Director of McGill and Emory Cancer Centers

Kunal Bhatia - Director, Healthcare Investment Banking, Cowen

Steven Ferguson - Deputy Director, Licensing and Entrepreneurship, National Institutes of Health

Dr. Michael Salgaller - Director of Tech Transfer, NCI | Supervisor, Invention Development and Marketing Unit (IDMU) 

Dr. Alfred Slanetz - CEO Geneius Biotechnology | Former CEO, Bluebird Bio | Former Director of New Production Development, Genetech

Dr. Phil Friedlander - Professor, Mt. Sinai

To register for the conference, please go HERE.